Utah’s experimental use of an artificial intelligence system to autonomously renew prescriptions without physician oversight has triggered a major regulatory pushback. The state’s medical licensing board is now demanding the program’s immediate suspension, citing unaddressed safety risks and a lack of prior consultation.
In a strongly worded letter published on Friday, the Utah Medical Licensing Board revealed it had only learned of the pilot program—run in partnership with AI doctor startup Doctronic—after it had already been implemented. The board expressed deep concerns about the program’s potential to endanger patients.
"Proceeding with this agreement without consulting the Medical Board potentially places Utah citizens at risk and remains a major concern of the board. It is the strong recommendation of the Utah Medical Licensing Board that this program be immediately suspended pending further discussion."
The board’s letter underscores the urgency of its request, emphasizing that patient safety must take precedence over unregulated AI-driven healthcare innovations. The pilot program, which allows AI systems to renew prescriptions without direct physician involvement, has drawn sharp criticism from medical professionals across the state.
As of now, the future of the AI-powered prescription renewal system in Utah remains uncertain. The medical board’s call for suspension signals a potential turning point in the debate over AI’s role in healthcare, particularly in high-stakes areas like prescription management.
Related articles
Kennedy Swaps Vaccine Rhetoric for Story Time but Can’t Quite Change the Subject
Here in Washington, we’ve been hearing about tensions between the White House and one of its most controversial — but, at least in some circles, most...
Makary’s departure and Cassidy’s tenuous Senate seat
This week’s episode of “The Readout LOUD” is all about health politics. We bring on FDA reporter Lizzy Lawrence to discuss Makary’s departure — why he...
STAT+: The hunt for FDA’s next leader
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to...
Air pollution tied to worse outcomes after surgery
New research on Utah’s Wasatch Front—which occasionally experiences the worst air quality in the nation—has found an association between high air poll...
STAT+: Why big digital health players are missing from Medicare’s chronic care experiment
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it deli...
8,500 Daily Steps Can Help You Lose Weight and Keep It Off
A new study demonstrates that 8,500 daily steps is the sweet spot for weight management. Stewart Cohen/Getty Images Walking 8,500 steps per day can he...
STAT+: Regenxbio says Duchenne gene therapy succeeded in clinical trial, paving way for FDA submission
Regenxbio said Thursday that its experimental gene therapy for Duchenne muscular dystrophy produced sufficiently high levels of a miniaturized muscle...
STAT+: CREATE Medicines, a biotech company developing CAR-T therapies, raises $122 million
CREATE Medicines has a new name, an expanded pipeline, and now fresh funding to propel the company’s first CAR-T candidates through human trials. Up u...